Inventor profile of:

Birgitte P.S. JACKY

City:

Orange, California

Country:

United States

Published Applications:

16

Last publication date:

2023-10-19

Top Assignees for applications by Birgitte P.S. JACKY

The entities that hold a legal rights for patent applications filed by inventor JACKY Birgitte P.S.:

Recent patent applications by JACKY Birgitte P.S.

Birgitte P.S. JACKY from Orange, US has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2023-10-19
US20230332126A1
Chemistry; metallurgy

Botulinum Neurotoxin Proteins and Methods to Engineer and Generate Same

#2 | 2023-09-28
US20230302103A1
Human necessities

BOTULINUM NEUROTOXIN FOR TREATMENT OF DISORDERS ASSOCIATED WITH MELANOCYTE HYPERACTIVITY AND/OR EXCESS MELANIN

#3 | 2021-09-09
US20210277377A1
Chemistry; metallurgy

BOTULINUM TOXIN CELL BINDING DOMAIN POLYPEPTIDES AND METHODS OF USE FOR TREATMENTS OF FIBROSIS ASSOCIATED DISORDERS

#4 | 2021-06-03
US20210162027A1
Human necessities

BOTULINUM NEUROTOXIN FOR TREATMENT OF DISORDERS ASSOCIATED WITH MELANOCYTE HYPERACTIVITY AND/OR EXCESS MELANIN

#5 | 2019-06-20
US20190185837A1
Chemistry; metallurgy

BOTULINUM TOXIN CELL BINDING DOMAIN POLYPEPTIDES AND METHODS OF USE FOR TREATMENTS OF FIBROSIS ASSOCIATED DISORDERS

#6 | 2019-06-20
US20190185523A1
Chemistry; metallurgy

Botulinum toxin cell binding domain polypeptides and methods of use for skin rejuvenation

#7 | 2018-12-06
US20180344820A1
Human necessities

Botulinum neurotoxin for treatment of disorders associated with melanocyte hyperactivity and/or excess melanin

#8 | 2017-08-03
US20170218334A1
Chemistry; metallurgy

Cells Useful for Immuno-Based Botulinum Toxin Serotype A Activity Assays

#9 | 2013-09-05
US20130230502A1
Human necessities

METHODS OF TREATING CANCER USING OPIOD RETARGETED ENDOPEPIDASES

#10 | 2013-08-29
US20130224178A1
Human necessities

Methods of Treating Cancer Using Glucagon-Like Hormone Retargeted Endopepidases

#11 | 2013-08-01
US20130195838A1
Human necessities

Methods of Treating Cancer Using Growth Factor Retargeted Endopeptidases

#12 | 2012-08-16
US20120207743A1
Chemistry; metallurgy

Inhibiting Aberrant Blood Vessel Formation Using Retargeted Endopeptidases

#13 | 2012-08-16
US20120207742A1
Chemistry; metallurgy

Treatments Using PSMA Ligand Endopeptidases

#14 | 2012-08-16
US20120207734A1
Human necessities

Methods of Inhibiting Aberrant Blood Vessel Formation Using Opioid Retargeted Endpeptidases

#15 | 2012-08-16
US20120207733A1
Human necessities

Treating a Disease of Hyperproliferation Using Retargeted Endopeptidases

#16 | 2012-08-16
US20120207704A1
Chemistry; metallurgy

Inhibiting Aberrant Blood Vessel Formation Using Growth Factor Retargeted Endopeptidases

InventorID:

364709 ⎘